Publication:
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study.

No Thumbnail Available

Date

2017-10-10

Authors

Fernández-de-Misa, R
Hernández-Machín, B
Servitje, O
Valentí-Medina, F
Maroñas-Jiménez, L
Ortiz-Romero, P L
Sánchez Schmidt, J
Pujol, R M
Gallardo, F
Pau-Charles, I

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Data regarding response to treatment in lymphomatoid papulosis (LyP) are scarce. To assess the daily clinical practice approach to LyP and the response to first-line treatments. This was a retrospective study enrolling 252 patients with LyP. Topical steroids, methotrexate and phototherapy were the most common first-line treatments, prescribed for 35%, 20% and 14% of the patients, respectively. Complete response (CR) was achieved in 48% of treated patients. Eczematous lesions significantly increased relative risk (RR) of not achieving CR (RR = 1.76; 95% CI 1.16-2.11). Overall median time to CR was 10 months (95% CI 6-13 months), and 78% of complete responders showed cutaneous relapse; both results were similar for all treatment groups (P > 0.05). Overall estimated median disease-free survival (DFS) was 11 months (95% CI 9-13 months) but DFS for patients treated with phototherapy was 23 months (95% CI 10-36 months; P  0.05). Overall estimated median disease-free survival (DFS) was 11 months (95% CI 9-13 months) but DFS for patients treated with phototherapy was 23 months (95% CI 10-36 months; P  Current epidemiological, clinical and pathological data support previous results. Topical steroids, phototherapy and methotrexate are the most frequently prescribed first-line treatments. Although CR and cutaneous relapse rates do not differ between them, phototherapy achieves a longer DFS. Presence of Type A LyP and use of topical steroid or methotrexate were associated with an increased risk of early relapse.

Description

MeSH Terms

Administration, Topical
Adolescent
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Child
Child, Preschool
Disease-Free Survival
Female
Humans
Infant
Lymphomatoid Papulosis
Male
Methotrexate
Middle Aged
Mycosis Fungoides
Neoplasms, Multiple Primary
Phototherapy
Receptors, Antigen, T-Cell
Retrospective Studies
Skin Neoplasms
Steroids
Young Adult

DeCS Terms

CIE Terms

Keywords

Citation